focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,122.00
Bid: 12,120.00
Ask: 12,122.00
Change: -50.00 (-0.41%)
Spread: 2.00 (0.017%)
Open: 12,180.00
High: 12,188.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland Eyes Vaccines For All Adults By September Despite Supply Fears

Tue, 26th Jan 2021 16:10

(Alliance News) - Ireland's target remains to vaccinate every adult in the country by September, despite disruptions to the supply chain, the upper house of the country's legislature, has heard.

Junior Minister Anne Rabbitte, speaking on behalf of the Health Minister, said the Irish government has "significant concerns" that one vaccine producer, AstraZeneca PLC, will be unable to meet its initial delivery commitments.

This has led to some "adjustments" to the government's target of vaccinating 700,000 people by the end of March, Rabbitte said.

The goal of vaccinating all adults by September remains the target, but it is contingent on steady flow of vaccines.

Rabbitte said: "The minister for health previously stated that he expected all adult residents to be vaccinated by September.

"That remains our target.

"However, as Minister Donnelly stressed, it is contingent on existing commitments on the approval, supply and delivery of vaccines."

The AstraZeneca vaccine is crucial to the government's planned vaccine delivery schedule.

It is scheduled for approval by the European Medicines Agency on Friday, but the company recently announced it will initially supply considerably fewer doses than agreed with the EU.

The announcement has caused outrage in the EU, which pre-financed the production and delivery of the vaccine.

The new delivery schedule is "not acceptable", European Health Commissioner Stella Kyriakides has warned the company.

On Tuesday, Rabbitte also criticised the company over the delays.

She said: "Of significant concern is the recent indication that AstraZeneca will not be available to meet its initial delivery commitments.

"It is estimated that deliveries in February will be at the low range of what was anticipated, and there will be further significant impact in March.

"The Department of Health is monitoring this change of situation, and is continually engaging with the commission and the company.

"The minister is very concerned that this supply issue was only communicated to the member states just a week before the scheduled authorisation was to be given for the vaccine."

Rabbitte also warned that the arrival of the vaccines and the prospect of a return to normality "gives rise to public expectation that cannot be met in the short term".

The EU had expected to receive 100 million doses of the AstraZeneca vaccine in the first quarter of the year.

It is now feared it will receive only half that amount.

Brussels has threatened to block exports of Covid-19 vaccines outside of the bloc as a result of the ongoing row.

As of Sunday, the HSE has administered 143,000 vaccine doses in Ireland.

Two doses delivered three or four weeks apart are required for the vaccines currently in use in Ireland, Pfizer Inc/BioNTech SE and Moderna Inc.

The HSE began administration of the second doses of the vaccine last week.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.